Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Molecular Oncology

• Publication date

  2013-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molonc.2013.02.018PMID 23562353PMCID PMC5528474
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The proof and measurement of association between two things.

  2015cited by this paper
• Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins

  2013cited by this paper
• miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors

  2011cited by this paper
• hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma.

  2010cited by this paper
• Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density

  2010cited by this paper
• Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer

  2010cited by this paper
• Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population‐based lymph node negative breast cancer cohort

  2010cited by this paper
• Mammalian microRNAs predominantly act to decrease target mRNA levels

  2010cited by this paper
• High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer

  2010cited by this paper
• The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer

  2010cited by this paper
• Genomic Architecture Characterizes Tumor Progression Paths and Fate in Breast Cancer Patients

  2010cited by this paper
• In Silico Ascription of Gene Expression Differences to Tumor and Stromal Cells in a Model to Study Impact on Breast Cancer Outcome

  2010cited by this paper
• A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers

  2010cited by this paper
• HER2-positive breast cancer: beyond trastuzumab.

  2010cited by this paper
• Phenotype and 244k array‐CGH characterization of chromosome 13q deletions: An update of the phenotypic map of 13q21.1‐qter

  2009influential reference
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer

  2009cited by this paper
• Correlations between RNA and protein expression profiles in 23 human cell lines

  2009cited by this paper
• 3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma.

  2009cited by this paper
• Calpain-1 Cleaves and Activates Caspase-7*

  2009cited by this paper
• High cyclin B1 expression is associated with poor survival in breast cancer

  2009cited by this paper
• Long noncoding RNAs: functional surprises from the RNA world.

  2009cited by this paper
• Modification‐specific proteomics: Strategies for characterization of post‐translational modifications using enrichment techniques

  2009cited by this paper
• High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c.

  2009cited by this paper
• ESR1 gene amplification in breast cancer: a common phenomenon?

  2008cited by this paper
• ESR1 gene amplification in breast cancer: a common phenomenon?

  2008cited by this paper
• The impact of microRNAs on protein output

  2008cited by this paper
• Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol

  2008cited by this paper
• Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors

  2008cited by this paper
• ESR1 gene amplification in breast cancer: a common phenomenon?

  2008cited by this paper
• 4E-Binding Protein 1, A Cell Signaling Hallmark in Breast Cancer that Correlates with Pathologic Grade and Prognosis

  2007cited by this paper
• Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation

  2007cited by this paper
• Relative Impact of Nucleotide and Copy Number Variation on Gene Expression Phenotypes

  2007cited by this paper
• TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer

  2007cited by this paper
• Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer

  2007cited by this paper
• The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

  2006cited by this paper
• Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis

  2006cited by this paper
• Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.

  2006cited by this paper
• Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells

  2006cited by this paper
• Lapatinib plus capecitabine for HER2-positive advanced breast cancer.

  2006cited by this paper
• The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers

  2004cited by this paper
• Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals

  2003influential reference
• Repeated observation of breast tumor subtypes in independent gene expression data sets

  2003cited by this paper
• Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.

  2003cited by this paper
• Protein microarrays: Molecular profiling technologies for clinical specimens

  2003cited by this paper
• Impact of DNA amplification on gene expression patterns in breast cancer.

  2002cited by this paper
• Utility of reverse phase protein arrays: applications to signalling pathways and human body arrays.

  2002cited by this paper
• Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors

  2002cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis.

  2001cited by this paper
• Expression of the G2-M checkpoint regulators cyclin B1 and P34CDC2 in breast cancer: a correlation with cellular kinetics.

  1999cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

  1998cited by this paper
• Tamoxifen for early breast cancer: an overview of the randomised trials

  1998cited by this paper
• Cyclin‐d1‐gene amplification and expression in breast carcinoma: Relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21waf1 immunohistochemical expression

  1997cited by this paper
• Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancer.

  1996cited by this paper
• Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization.

  1996cited by this paper
• Transcriptional regulation of estrogen receptor in breast carcinomas

  1995cited by this paper
• A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.

  1989cited by this paper
• Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.

  1987cited by this paper
• Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer

  1980cited by this paper
• Molecular Systems Biology Peer Review Process File Global Analysis of Genome, Transcriptome and Proteome Reveals the Response to Aneuploidy in Human Cells Transaction Report

  year unknowncited by this paper

• Cancer subclone detection based on DNA copy number in single-cell and spatial omic sequencing data

  2025cites this paper
• Segmental copy number amplifications are stable in the absence of selection

  2025cites this paper
• Transcriptomic and proteomic ramifications of segmental amplification in Escherichia coli

  2025cites this paper
• The transcriptomic and proteomic ramifications of segmental amplification

  2024cites this paper
• Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes

  2024cites this paper
• Omics-based molecular classifications empowering in precision oncology

  2024cites this paper
• Omics Technologies Improving Breast Cancer Research and Diagnostics

  2023cites this paper
• Multilevel Gene Expression Changes in Lineages Containing Adaptive Copy Number Variants

  2023cites this paper
• Copy number variation alters local and global mutational tolerance

  2023cites this paper
• Clinical application of the anti‐human telomerase reverse transcriptase (hTERT) antibody (SCD‐A7) immunocytochemistry in liquid‐based urine cytology: A prospective, single institute study

  2023cites this paper
• Cancer subclone detection based on DNA copy number in single cell and spatial omic sequencing data

  2022cites this paper
• Integrative Multi-OMICs Identifies Therapeutic Response Biomarkers and Confirms Fidelity of Clinically Annotated, Serially Passaged Patient-Derived Xenografts Established from Primary and Metastatic Pediatric and AYA Solid Tumors

  2022cites this paper
• Copy number variants alter local and global mutational tolerance

  2022cites this paper
• NetCellMatch: Multiscale Network‐Based Matching of Cancer Cell Lines to Patients Using Graphical Wavelets

  2022cites this paper
• Proteomic-Based Machine Learning Analysis Reveals PYGB as a Novel Immunohistochemical Biomarker to Distinguish Inverted Urothelial Papilloma From Low-Grade Papillary Urothelial Carcinoma With Inverted Growth

  2022cites this paper
• Proteome-centric cross-omics characterization and integrated network analyses of triple-negative breast cancer.

  2022cites this paper
• Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues.

  2021cites this paper
• Elastic Net Models Based on DNA Copy Number Variations Predicts Clinical Features, Expression Signatures, and Mutations in Lung Adenocarcinoma

  2021cites this paper
• Luminal A Breast Cancer Co-expression Network: Structural and Functional Alterations

  2021cites this paper
• Process Engineering of Biopharmaceutical Production in Moss Bioreactors via Model-Based Description and Evaluation of Phytohormone Impact

  2021cites this paper
• Gene Co-Expression in Breast Cancer: A Matter of Distance

  2021cites this paper
• Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma

  2020cites this paper
• Typing, grading, and staging of cases of tumor

  2020cites this paper
• Evolution of new enzymes by gene duplication and divergence

  2020cites this paper
• Copy number variation of IL17RA gene and its association with the ankylosing spondylitis risk in Iranian patients: a case-control study

  2020cites this paper
• Protein Kinase C Isozymes Associated With Relapse Free Survival in Non-Small Cell Lung Cancer Patients

  2020cites this paper
• MN1 overexpression with varying tumor grade is a promising predictor of survival of glioma patients

  2020cites this paper
• Considerations for feature selection using gene pairs and applications in large-scale dataset integration, novel oncogene discovery, and interpretable cancer screening

  2020cites this paper
• Integrated Omics of Metastatic Colorectal Cancer.

  2020cites this paper
• An integrated landscape of protein expression in human cancer

  2019cites this paper
• Epithelial-mesenchymal transition as a mechanism of resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma

  2019cites this paper
• A Bayesian two-way latent structure model for genomic data integration reveals few pan-genomic cluster subtypes in a breast cancer cohort

  2019cites this paper
• Breast cancer quantitative proteome and proteogenomic landscape

  2019cites this paper
• The androgen receptor expression and association with patient's survival in different cancers.

  2019cites this paper
• Genetic determinants of the molecular portraits of epithelial cancers

  2019cites this paper
• Challenges in proteogenomics: a comparison of analysis methods with the case study of the DREAM proteogenomics sub-challenge

  2019cites this paper
• miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer.

  2019cites this paper
• Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells.

  2018cites this paper
• Credentialing Individual Samples for Proteogenomic Analysis *

  2018cites this paper
• Tolerance of Chromosomal Instability in Cancer: Mechanisms and Therapeutic Opportunities.

  2018cites this paper
• Role of columnar cell lesions in breast carcinogenesis: analysis of chromosome 16 copy number changes by multiplex ligation-dependent probe amplification

  2018cites this paper
• Clustering multilayer omics data using MuNCut

  2018cites this paper
• A Bayesian Two-Way Latent Structure Model for Genomic Data Integration Reveals Few Pan-Genomic Cluster Subtypes in a Breast Cancer Cohort

  2018cites this paper
• Investigating Coordinated Architectures Across Clusters in Integrative Studies: a Bayesian Two-Way Latent Structure Model

  2018cites this paper
• Integrated Multi‐Omic Analyses Support Distinguishing Secretory Carcinoma of the Breast from Basal‐Like Triple‐Negative Breast Cancer

  2018cites this paper
• Reconstruction of pathway modification induced by nicotinamide using multi-omic network analyses in triple negative breast cancer

  2017cites this paper
• ERBB2 as a driver of an invasive phenotype of cells grown in 3D culture and an important regulator of oncogenic miRNAs' expression in breast cancer

  2017cites this paper
• Comparison of Human Factor IX Abundance and mRNA Expression Levels In Stable Insect and Mammalian Cells

  2017influential citation
• Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

  2017cites this paper
• Amplification and protein overexpression of cyclin D1: Predictor of occult nodal metastasis in early oral cancer

  2017cites this paper
• Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors

  2017cites this paper
• Comprehensive Analysis of Cancer-Proteogenome to Identify Biomarkers for the Early Diagnosis and Prognosis of Cancer

  2017cites this paper
• Protein kinase C as a tumor suppressor.

  2017cites this paper
• Efficient bioreduction of 2-hydroxyacetophenone to (S)-1-phenyl-1, 2-ethanediol through homologous expression of (S)-carbonyl reductase II in Candida parapsilosis CCTCC M203011

  2016cites this paper
• Current and Emerging Targeting Strategies for Treatment of Pancreatic Cancer.

  2016cites this paper
• Detection of Isoforms Differing by a Single Charge Unit in Individual Cells.

  2016cites this paper
• Effects of aneuploidy on gene expression: implications for cancer

  2016cites this paper
• Low Gene Dosage of Cdc42 Is Not Associated with Protein Dysfunction in Patients with Colorectal Cancer

  2016cites this paper
• Metabolic clusters of breast cancer in relation to gene- and protein expression subtypes

  2016cites this paper
• Control of Gene Expression by RNA Binding Protein Action on Alternative Translation Initiation Sites

  2016cites this paper
• Molecular portraits: the evolution of the concept of transcriptome-based cancer signatures

  2015cites this paper
• Consequences of Aneuploidy in Cancer: Transcriptome and Beyond.

  2015cites this paper
• PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer

  2015cites this paper
• Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer

  2015cites this paper
• Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor.

  2015cites this paper
• Molecular Abnormalities in Tumors

  2015cites this paper
• Coiled-coil domain containing 68 (CCDC68) demonstrates a tumor suppressive role in pancreatic ductal adenocarcinoma

  2014cites this paper
• The multitude of molecular analyses in cancer: the opening of Pandora’s box

  2014cites this paper
• A pan-cancer proteomic perspective on The Cancer Genome Atlas

  2014cites this paper
• Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors

  2013influential citation
• Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins

  2013cites this paper
• Reliable PCR quantitation of estrogen, progesterone and ERBB2 receptor mRNA from formalin-fixed, paraffin-embedded tissue is independent of prior macro-dissection

  2013cites this paper
• Post-transcriptional mechanisms modulate the consequences of adaptive copy number variation

  year unknowncites this paper